Q9C0B1 (FTO_HUMAN) Homo sapiens (Human)

Alpha-ketoglutarate-dependent dioxygenase FTO UniProtKBInterProSTRINGInteractive Modelling

505 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4)

Available Structures

24 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of FTO in complex with m6dA modified ssDNAhomo-2-mer37-499
MN;OGA;
Assess
Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with CCO10monomer32-504
ZN;NKG;
Assess
Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with N-[(3-…monomer32-503
ZN;MD6;GOL;
Assess
Structural complex of FTO/fluoresceinmonomer32-503
AKG;FLU;MN;
Assess
Crystal structure of FTO bound to a selective inhibitormonomer32-503
OGA;JMS;MN;GOL;
Assess
Structural complex of 5-aminofluorescein bound to the FTO proteinmonomer32-503
AKG;A4F;MN;
Assess
Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with N-oxal…monomer32-503
OGA;GOL;NI;
Assess
Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with N-[(1-…monomer32-503
ZN;UN9;
Assess
Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with 5-carb…monomer32-503
ZN;GOL;8XQ;
Assess
Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with pyridi…monomer32-503
ZN;GOL;PD2;
Assess
Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with SS81monomer32-503
ZN;HZX;
Assess
Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with citrat…monomer32-503
ZN;RHN;FLC;
Assess
Crystal structure of human FTO in complex with acylhydrazine inhibitor 16monomer32-503
NI;640;
Assess
Crystal structure of human FTO in complex with small-molecule inhibitorsmonomer32-503
ZN;PD9;
Assess
Co-crystal structure of FTO bound to 22monomer32-502
ZL6;AKG;
Assess
Crystal structure of RNA dioxygenase bound with an inhibitormonomer32-502
AKG;8S3;
Assess
A Novel Inhibitor of the Obesity-Related Protein FTOmonomer32-502
SO4;FIJ;AKG;FE2;
Assess
Co-crystal structure of FTO bound to 6emonomer32-502
AKG;MN;943;
Assess
Crystal structure of human FTO in complex with acylhydrazine inhibitor 21monomer32-502
DGR;NI;
Assess
Crystal structure of human FTO in complex with subfamily-selective inhibitor 12monomer32-502
NI;6MK;
Assess
Crystal structure of FTO-IN115monomer32-500
CL;FE2;AKG;58W;
Assess
Structural complex of FTO bound with Dac51monomer32-500
OGA;B6C;
Assess
Crystal structure of the fat mass and obesity associated (FTO) protein reveals basis for its substr…monomer32-499
3DT;OGA;FE2;
Assess
Crystal structure of human FTO in complex with small-molecule inhibitorsmonomer32-499
7YC;ZN;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4qho.1.Amonomer0.8732-504
ZN;NKG;100.00
Assess

3 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 24qho.1.Amonomer0.7927-126
92.08
Assess
Isoform 36ak4.1.Amonomer0.688-58
94.34
Assess
Isoform 44qho.1.Amonomer0.831-105
100.00
Assess